Sotatercept for pulmonary hypertension
Part of Heart & circulation, Lungs & breathing clinical trials.
This study looks at how a medication called sotatercept affects the blood vessels in the lungs over time. It aims to see if it can help improve how the heart and lungs work in people with pulmonary hypertension.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have Group 1 pulmonary hypertension (including idiopathic, drug-induced, or hereditary types)
- You have not used sotatercept before
- You have adequate kidney function (not severely reduced)
- You are not pregnant (if female)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug, tiprelestat, added to your current treatment for pulmonary arterial hypertension (PAH). It aims to see if it improves your symptoms and exercise ability.
This study tests a medicine called sotatercept to see if it can improve how the right side of your heart pumps in people with PAH. It may help you feel better and slow down the disease.
This study looks at how well the drug Sotatercept works for people with pulmonary hypertension (high blood pressure in the lungs) in a real-world clinic setting. If you are already taking Sotatercept, you may be able to join.
This trial tests how a new medication, sotatercept, affects the heart and lungs in people with pulmonary arterial hypertension (PAH). Using a special scan, the study looks at how the drug changes the blood vessels and heart over time to see if it helps.
This study tests an investigational drug called sotatercept for people who have a specific type of high blood pressure in the lungs that happens along with heart failure with preserved ejection fraction (a stiff heart muscle). The treatment aims to improve your ability to be active and reduce symptoms, and the study will compare it to a placebo to see if it helps.
This trial tests a new combination of three medicines (including an experimental drug called sotatercept) for people recently diagnosed with PAH. The goal is to see if this early, powerful treatment works better than standard care in improving heart and lung function.
Hear when a new Pulmonary Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.